1 / 9

Enhancing Immunization Coverage for New Vaccines: Perception, Program, & Financing

This discussion focuses on the introduction of new vaccines, challenges with cost and coverage, and proposals to address insurance coverage and underinsurance issues. Recommendations aim to ensure access to new vaccines without financial barriers.

rosalyn-yanez
Télécharger la présentation

Enhancing Immunization Coverage for New Vaccines: Perception, Program, & Financing

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Assuring coverage with newly introduced vaccines:Perception, Program, & Financing Alan R. Hinman, MD, MPH Subcommittee on Immunization Coverage June 7, 2006

  2. Issues - 1 • Several new vaccines recently, or about to be, introduced into routine schedule for young children and adolescents • Pneumococcal conjugate • Meningococcal conjugate • Rotavirus • Human papillomavirus

  3. Issues - 2 • Newer vaccines more expensive than “traditional” vaccines • VFC vaccine cost to fully immunize a child • 1995 ~$150 • 2006 ~$850 (with rotavirus but without HPV) • 2008 >$1,000?

  4. Issues - 3 3. Limited sources of financing for vaccines • Public • Section 317 • VFC • State/local government • Private • Insurance • Out-of-pocket

  5. Issues - 4 • Meeting the increasing costs is a major challenge • VFC covers “automatically” • Insurance covers after a + short delay • 317 covers after significant delay • State/local governments may/may not cover after a significant delay (e.g., universal “light”) • Underinsured remain uncovered 5. Remember that vaccine price is not the only cost – reimbursement for administration

  6. Issues - 5 • Recent expansion in number and costs of vaccines represents a major (but temporary) “bubble” • After HPV, there will be a time gap before additional new vaccines are introduced for universal use • If we don’t now fix the system we may face bigger problems in the future

  7. Proposal - 1 • Subcommittee on Immunization Coverage should address the problem of insurance coverage/underinsurance for new vaccines • Define “underinsured” • Ascertain current prevalence of underinsured and likely projection for future • NIS now looking at underinsured • AHIP survey of members

  8. Proposal - 2 • Determine attitudes/practices of employers/benefits managers/providers • Engage NBGH • Engage benefits managers • Engage providers • Address reimbursement for providers • Engage major stakeholders in discussion • Assure public involvement

  9. Proposal - 3 • Develop recommendations to assure that all persons recommended to receive new vaccines will have access to these vaccines without financial impediment to themselves or their providers

More Related